Invention Grant
- Patent Title: Vaccine comprising Streptococcus pneumoniae capsular polysaccharide conjugates
-
Application No.: US12665247Application Date: 2008-06-24
-
Publication No.: US09610339B2Publication Date: 2017-04-04
- Inventor: Ralph Leon Biemans , Nathalie Marie-Josephe Garçon , Philippe Vincent Hermand , Jan Poolman , Marcelle Paulette Van Mechelen
- Applicant: Ralph Leon Biemans , Nathalie Marie-Josephe Garçon , Philippe Vincent Hermand , Jan Poolman , Marcelle Paulette Van Mechelen
- Applicant Address: BE Rixensart
- Assignee: GlaxoSmithKline Biologicals, S.A.
- Current Assignee: GlaxoSmithKline Biologicals, S.A.
- Current Assignee Address: BE Rixensart
- Agent Barbara J. Carter
- Priority: GB0712420.9 20070626; GB0712428.2 20070626; GB0712435.7 20070626
- International Application: PCT/EP2008/057997 WO 20080624
- International Announcement: WO2009/000824 WO 20081231
- Main IPC: A61K39/09
- IPC: A61K39/09 ; A61K47/48 ; A61K39/00 ; A61K39/116
Abstract:
The present invention relates to an immunogenic composition comprising S. pneumoniae capsular saccharide conjugates from serotypes 19A and 19F wherein 19A is conjugated to a first bacterial toxoid and 19F is conjugated to a second bacterial toxoid. Methods of making and uses thereof are also described.
Public/Granted literature
- US20100239604A1 VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CONJUGATES Public/Granted day:2010-09-23
Information query
